ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,07175
0,00%
Bitcoin
66.552,76
0,55%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Pacira BioSciences Inc (PCRX)

  7. Pacira BioSciences Inc (PCRX) News

PCRX Pacira BioSciences Inc

28,13
-0,24 (-0,85%)
15 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Pacira BioSciences Inc PCRX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,24 -0,85% 28,13 01:13:42
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
27,90 27,77 28,27 28,13 28,37
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
14.6.202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202400:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.6.202423:14EDGAR2Form 8-K - Current report
13.6.202416:19EDGAR2Form 144 - Report of proposed sale of securities
12.6.202422:23EDGAR2Form 144 - Report of proposed sale of securities
11.6.202417:46EDGAR2Form 144 - Report of proposed sale of securities
05.6.202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.6.202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.6.202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.6.202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.5.202414:00GLOBEPacira BioSciences to Participate in Fireside Chat at the..
14.5.202422:00EDGAR2Form 8-K - Current report
10.5.202413:00GLOBEPacira BioSciences, Inc. Announces Pricing of $250.0 Million..
08.5.202422:13EDGAR2Form 8-K - Current report
08.5.202422:05GLOBEPacira BioSciences, Inc. Announces Proposed Offering of..
07.5.202422:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.5.202422:01EDGAR2Form 8-K - Current report
07.5.202422:00GLOBEPacira BioSciences Reports First Quarter 2024 Financial..
07.5.202414:00GLOBEPacira BioSciences to Participate in Fireside Chat at the..
30.4.202414:00GLOBEPacira to Report First Quarter 2024 Financial Results on..
02.4.202414:00GLOBEPacira BioSciences to Participate in Fireside Chat at the..
13.3.202412:00GLOBEPacira BioSciences Announces PCRX-201 Granted Regenerative..
06.3.202414:00GLOBEPacira BioSciences to Participate in Fireside Chat at the..
29.2.202421:33EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29.2.202414:03EDGAR2Form 8-K - Current report
29.2.202414:00GLOBEPacira BioSciences Reports Fourth Quarter and Full-Year 2023..
22.2.202414:00GLOBEPacira to Report 2023 Financial Results on Thursday February..
15.2.202414:36GLOBEPacira Announces Publication of Pivotal Study of EXPAREL as..
07.2.202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202414:00GLOBEPacira BioSciences Awarded Brand Pharmaceuticals Agreement..
01.2.202416:45PRNUSG.O.A.T. Bowl I Registration Open to 4 Additional Pickleball..
04.1.202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202423:18EDGAR2Form 3 - Initial statement of beneficial ownership of..
04.1.202423:02EDGAR2Form 8-K - Current report
04.1.202423:00GLOBEPacira Reports Preliminary Unaudited Fourth Quarter and..
03.1.202414:00GLOBEPacira BioSciences to Present at the 42nd Annual J.P. Morgan..
21.12.202313:33EDGAR2Form 8-K - Current report
21.12.202313:30GLOBEPacira Appoints Frank D. Lee as Chief Executive Officer
08.12.202301:44EDGAR2Form 3 - Initial statement of beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
PCRX
Pacira BioSciences
USOTC
ERYTF
Eagle Royalties (CE)
USOTC
FRDSF
4DS Memory (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten